← SynDRA
ONALESPIB
SynDRA canonical compound SYN0023879 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | HSP90AA1 |
|---|
| Mechanism of action | HSP inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- HSP90AA1 INHIBITOR
- Heat shock protein HSP90 inhibitor
- HSP90AB1 INHIBITOR
- HSP inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- HSP90B1
- ABL1
- AURKA
- BRD4
- BRPF1
- CDK2
- CSNK1D
- CYP2C19
- CYP2C9
- FGFR2
- GSK3B
- HDAC6
- KCNH2
- MAPK1
- TRIM24
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ATXN2
- CP2C9
- KSYK
- MITF
- NSD2
- SYK
- TFE3
Cross-references
Synonyms
- AT-13387
- AT13387
- A13387
- ATI-13387X
- ATI13387X
- CPD 35
- ONALESPIB (AT13387)
- XJX
- AT 13387
- Onalespib (AT13387)
- (2,4-Dihydroxy-5-isopropylphenyl)(5-((4-methylpiperazin-1-yl)methyl)isoindolin-2-yl)methanone
- Q7Y33N57ZZ
- (2,4-Dihydroxy-5-isopropylphenyl)-(5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl)methanone
- OnalespibAT13387,ATI13387X
- 912999-49-6 (free base)
- Methanone, (1,3-dihydro-5-((4-methyl-1-piperazinyl)methyl)-2H-isoindol-2-yl)(2,4-dihydroxy-5-(1-methylethyl)phenyl)-
- UNII-Q7Y33N57ZZ
- (2,4-Dihydroxy-5-propan-2-ylphenyl)-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydroisoindol-2-yl]methanone;(2,4-Dihydroxy-5-propan-2-ylphenyl)-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydroisoindol-2-yl]methanone
- Onalespib [USAN:INN]
- onalespibum
- Onalespib [USAN]
- OnalespibAT-13387
- ONALESPIB [INN]
- Onalespib (USAN/INN)
- ONALESPIB [WHO-DD]
- MLS006011085
- SCHEMBL382780
- CHEMBL1214827
- DTXSID80238485
- CHEBI:140592
- HMS3654O12
- BCP03601
- EX-A1798
- BDBM50005782
- NSC749712
- NSC763579
- s1163
- ZINC43208226
- AKOS027338622
Look up ONALESPIB in the interactive SynDRA portal →